lobbying_filings_raw: c4dcf8d3-aed9-4e88-a98d-2dd97873c4c3

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence
c4dcf8d3-aed9-4e88-a98d-2dd97873c4c3 Q4 401103524 ADVANCED POLICY CONSULTING, LLC 199373 AMGEN USA INC. 2017 fourth_quarter 2018-01-04T09:17:39.753000-05:00 50000.0 0 0 0 {"url": "https://lda.senate.gov/api/v1/filings/c4dcf8d3-aed9-4e88-a98d-2dd97873c4c3/", "filing_uuid": "c4dcf8d3-aed9-4e88-a98d-2dd97873c4c3", "filing_type": "Q4", "filing_type_display": "4th Quarter - Report", "filing_year": 2017, "filing_period": "fourth_quarter", "filing_period_display": "4th Quarter (Oct 1 - Dec 31)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/c4dcf8d3-aed9-4e88-a98d-2dd97873c4c3/print/", "filing_document_content_type": "text/html", "income": "50000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Matt McGinley", "dt_posted": "2018-01-04T09:17:39.753000-05:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "2503-D Harrison Street North #1210", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Arlington", "registrant_state": "VA", "registrant_zip": "22207", "registrant": {"id": 401103524, "url": "https://lda.senate.gov/api/v1/registrants/401103524/", "house_registrant_id": null, "name": "ADVANCED POLICY CONSULTING, LLC", "description": "Consulting", "address_1": "2503-D Harrison Street North #1210", "address_2": null, "address_3": null, "address_4": null, "city": "Arlington", "state": "VA", "state_display": "Virginia", "zip": "22207", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "MATT MCGINLEY", "contact_telephone": "+1 703-536-1705", "dt_updated": "2026-01-19T16:30:30.581235-05:00"}, "client": {"id": 199373, "url": "https://lda.senate.gov/api/v1/clients/199373/", "client_id": 87, "name": "AMGEN USA INC.", "general_description": "Biotechnology healthcare products", "client_government_entity": false, "client_self_select": null, "state": "DC", "state_display": "District of Columbia", "country": "US", "country_display": "United States of America", "ppb_state": "DC", "ppb_state_display": "District of Columbia", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2015-03-04"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "Market based solutions to bring down the cost of drug prices. Centers for Medicare & Medicaid Services (CMS) new coding regulation on biosimilar drug products. Issuing new codes in a timely fashion for the Medicare End-Stage Renal Disease (ESRD) Program.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 62356, "prefix": null, "prefix_display": null, "first_name": "MATTHEW", "nickname": null, "middle_name": null, "last_name": "MCGINLEY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 198, "name": "Natl Economic Council (NEC)"}, {"id": 1, "name": "SENATE"}, {"id": 41, "name": "Treasury, Dept of"}]}, {"general_issue_code": "TAX", "general_issue_code_display": "Taxation/Internal Revenue Code", "description": "Tax Reform: International tax provisions as it relates to the taxation of income derived from intangible property. \nTax Reform: International tax provisions as it relates to U.S. companies who do business in Puerto Rico.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 62356, "prefix": null, "prefix_display": null, "first_name": "MATTHEW", "nickname": null, "middle_name": null, "last_name": "MCGINLEY", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}], "government_entities": [{"id": 136, "name": "Centers For Medicare and Medicaid Services (CMS)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 198, "name": "Natl Economic Council (NEC)"}, {"id": 1, "name": "SENATE"}, {"id": 41, "name": "Treasury, Dept of"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} VA US   DC DC US US Biotechnology healthcare products 0 0        

Links from other tables